These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38953039)
41. The Impact of Inadequate ("AX") Transbronchial Biopsies on Post-lung Transplant CLAD or Death. Levy L; Huszti E; Pal P; Tikkanen J; Ghany R; Keshavjee S; Martinu T; Singer LG Transplantation; 2021 Feb; 105(2):390-395. PubMed ID: 32150039 [TBL] [Abstract][Full Text] [Related]
42. Risk Factors of Early Allograft Dysfunction in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure After Deceased Donor Liver Transplant. Yi J; Zhou Z; Li Q; Chen G; He Z; Ma Y; Luo X; Si Z; Li J Exp Clin Transplant; 2022 Jul; 20(7):668-673. PubMed ID: 35924745 [TBL] [Abstract][Full Text] [Related]
43. Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants: a retrospective cohort analysis. Steinack C; Saurer P; Gautschi F; Hage R; Ortmanns G; Schuurmans MM; Gaisl T Swiss Med Wkly; 2022 Jul; 152():w30206. PubMed ID: 35964254 [TBL] [Abstract][Full Text] [Related]
44. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Hartwig MG; Anderson DJ; Onaitis MW; Reddy S; Snyder LD; Lin SS; Davis RD Ann Thorac Surg; 2011 Aug; 92(2):462-8; discussion; 468-9. PubMed ID: 21801907 [TBL] [Abstract][Full Text] [Related]
45. Peak post-transplant lung function in bilateral lung transplant recipients using a prediction model based on donor and recipient demographic characteristics. Azar M; Krishnan S; Stump TE; Gutteridge D; Roe DW; Hage C Respir Med; 2019 Aug; 155():29-35. PubMed ID: 31295675 [TBL] [Abstract][Full Text] [Related]
46. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients. Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033 [TBL] [Abstract][Full Text] [Related]
47. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
48. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors. Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774 [TBL] [Abstract][Full Text] [Related]
49. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction. Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480 [TBL] [Abstract][Full Text] [Related]
50. Utility of bile acids in large airway bronchial wash versus bronchoalveolar lavage as biomarkers of microaspiration in lung transplant recipients: a retrospective cohort study. Zhang CYK; Ahmed M; Huszti E; Levy L; Hunter SE; Boonstra KM; Moshkelgosha S; Sage AT; Azad S; Ghany R; Yeung JC; Crespin OM; Singer LG; Keshavjee S; Martinu T Respir Res; 2022 Aug; 23(1):219. PubMed ID: 36028826 [TBL] [Abstract][Full Text] [Related]
51. Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant. Avolio AW; Franco A; Schlegel A; Lai Q; Meli S; Burra P; Patrono D; Ravaioli M; Bassi D; Ferla F; Pagano D; Violi P; Camagni S; Dondossola D; Montalti R; Alrawashdeh W; Vitale A; Teofili L; Spoletini G; Magistri P; Bongini M; Rossi M; Mazzaferro V; Di Benedetto F; Hammond J; Vivarelli M; Agnes S; Colledan M; Carraro A; Cescon M; De Carlis L; Caccamo L; Gruttadauria S; Muiesan P; Cillo U; Romagnoli R; De Simone P JAMA Surg; 2020 Dec; 155(12):e204095. PubMed ID: 33112390 [TBL] [Abstract][Full Text] [Related]
52. Impact of lung transplantation on diastolic dysfunction in recipients with pretransplant pulmonary hypertension. Aggarwal R; Potel KN; Jackson S; Lemke NT; Kelly RF; Soule M; Diaz-Gutierrez I; Shumway SJ; Patil J; Hertz M; Nijjar PS; Huddleston SJ J Thorac Cardiovasc Surg; 2024 May; 167(5):1643-1653.e2. PubMed ID: 37741317 [TBL] [Abstract][Full Text] [Related]
53. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Frampton MW; Balmes JR; Bromberg PA; Stark P; Arjomandi M; Hazucha MJ; Rich DQ; Hollenbeck-Pringle D; Dagincourt N; Alexis N; Ganz P; Zareba W; Costantini MG Res Rep Health Eff Inst; 2017 Jun; 2017(192, Pt 1):1-107. PubMed ID: 31898880 [TBL] [Abstract][Full Text] [Related]
54. Bronchial Culture Growth From the Donor and Recipient as Predictive Factors in the Detection of Primary Graft Dysfunction and Pneumonia After Lung Transplant. Atagun Guney P; Uygun Kizmaz Y Exp Clin Transplant; 2022 Oct; 20(10):930-936. PubMed ID: 35607803 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model. Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831 [TBL] [Abstract][Full Text] [Related]
56. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation. Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of Risk Factors for Heart-Lung Transplant Recipient Outcome: An Analysis of the United Network for Organ Sharing Database. Shudo Y; Wang H; Lingala B; He H; Kim FY; Hiesinger W; Lee AM; Boyd JH; Currie M; Woo YJ Circulation; 2019 Oct; 140(15):1261-1272. PubMed ID: 31589491 [TBL] [Abstract][Full Text] [Related]
58. Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion. Divithotawela C; Cypel M; Martinu T; Singer LG; Binnie M; Chow CW; Chaparro C; Waddell TK; de Perrot M; Pierre A; Yasufuku K; Yeung JC; Donahoe L; Keshavjee S; Tikkanen JM JAMA Surg; 2019 Dec; 154(12):1143-1150. PubMed ID: 31596484 [TBL] [Abstract][Full Text] [Related]
60. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]